This “Rapid Evaluation” analysis gives you an independent perspective of your 340B program based on data from a variety of sources, including the “Definitive Healthcare” database that uses publicly available data for hospitals as well as existing client data This analysis shows where your hospital could be performing taking into consideration compliance guidelines, 340B best practices and the insights of the SUNRx team and their 340B program technology platform. There is no charge nor obligation for this service.
Why perform a Rapid Evaluation?
✓ No cost/no obligation
✓ Receive a “second opinion” of the potential of your 340B program
✓ Identify some areas of opportunity within your 340B program
✓ Identify some areas of risk
To request a no cost/no obligation Rapid Evaluation from SUNRx, please send our Regional Manager Bubba Bartlett an email at bbartlett@sunrx.com expressing interest in a Rapid Evaluation and providing 2-3 date options (30 minutes).
SUNRx is a healthcare technology company that assists healthcare facilities with 340B administration, including split billing and 340B contract pharmacy network administration. Our technology helps facilities optimize their supply chain and pharmacy operations and we help simplify complex program administration for Covered Entities. Based in San Diego, CA SUNRx has been managing 340B programs since 2006. With SUNRx, you’ll receive industry-leading expertise and hands-on customer support. It’s 340B. Simplified. To learn more visit https://www.sunrx.com/who-we-are.
The SDAHO Enterprises Endorsed Business Partner program was established to provide innovative and cost-effective solutions for our member hospitals and long-term care facilities across the healthcare continuum. The business partners selected are expected to meet high-quality standards and offer products or services which are designed to assist healthcare facilities avoid costs, recover revenue, reduce operating and capital expenses, improve management and quality, increase productivity, develop staff resources and apply new innovative strategies.